Cover Image

Guidance for industry for the submission documentation for sterilization process validation in applications for human and veterinary drug products.

Bibliographic Details
Corporate Authors:	Center for Drug Evaluation and Research (U.S.), Center for Veterinary Medicine (U.S.)
Format:	Government Document eBook
Language:	English
Published:	[Rockville, Md.] : Center for Drug Evaluation and Research : Center for Veterinary Medicine, [1994]
Subjects:	Drugs > Sterilization > United States. Drug approval > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS120591

Similar Items

Guidance for industry : submission of documentation in applications for parametric release of human and veterinary drug products terminally sterilized by moist heat processes.
Published: (2008)

Guidance for industry : submission of documentation in applications for parametric release of human and veterinary drug products terminally sterilized by moist heat processes.
Published: (2010)

Sterility, sterilisation and sterility assurance for pharmaceuticals : technology, validation and current regulations /
by: Sandle, Tim
Published: (2025)

Guidebook for drug regulatory submissions /
by: Weinberg, Sandy, 1950-
Published: (2009)

Sterile processing of pharmaceutical products : engineering practice, validation, and compliance in regulated environments /
by: Hout, Sam
Published: (2022)

Guidance for industry : accelerated approval products, submission of promotional materials.
Published: (1999)

Guidance for industry : variations in drug products that may be included in a single ANDA.
Published: (1998)

Guidance for industry : sterile drug products produced by aseptic processing, current good manufacturing practice.
Published: (2004)

Guidance for industry : Q3A impurities in new drug substances.
Published: (2008)

Guidance for industry : major, minor, and telephone amendments to abbreviated new drug applications.
Published: (2001)

Guidance for industry : NDA's : impurities in drug substances.
Published: (2000)

Guidance for industry : changes to an approved NDA or ANDA.
Published: (2004)

Guidance for industry : referencing discontinued labeling for listed drugs in abbreviated new drug applications.
Published: (2000)

Guidance for industry : changes to an approved NDA or ANDA, questions and answers.
Published: (2001)

Guidance for industry : ANDAs, impurities in drug products.
Published: (2005)

Guidance for industry : changes to an approved NDA or ANDA, specifications, use of enforcement discretion for compendial changes.
Published: (2004)

Guidance for industry : submitting marketing applications according to the ICH-CTD format, general considerations.
Published: (2001)

Guideline for submitting supporting documentation in drug applications for the manufacture of drug substances.
Published: (1987)

Concepts in sterile preparations and aseptic technique /
by: Ochoa, Pamella S.
Published: (2015)

Guidance for industry : ANDAs, impurities in drug substances.
Published: (2009)

Guidance for industry : providing regulatory submissions in electronic format : human pharmaceutical product applications and related submissions using the eCTD specifications.
Published: (2008)

Guidance for industry : botanical drug products.
Published: (2004)

Guidance for industry : M4, organization of the CTD.
Published: (2001)

Guidance for industry : antibacterial drug products, use of noninferiority studies to support approval.
Published: (2007)

Sterile products and aseptic techniques for the pharmacy technician /
by: Johnston, Mike (Pharmacy technician)
Published: (2011)

Achieving sterility in medical and pharmaceutical products /
by: Halls, Nigel A., 1945-
Published: (1994)

Guidance for industry : qualifying for pediatric exclusivity under section 505A of the Federal Food, Drug, and Cosmetic Act.
Published: (1999)

Guidance for industry : pre-approval information for registration of new veterinary medicinal products for food-producing animals with respect to antimicrobial resistance.
Published: (2004)

Guidance for industry : comparability protocols, chemistry, manufacturing, and controls information.
Published: (2003)

Guidance for industry : revising and ANDA labeling following revision of the RLD labeling.
Published: (2000)

Generic drug product development : solid oral dosage forms /
Published: (2005)

Veterinary pharmacology in the pharmaceutical industry : proceedings of the ninth biennial symposium, American Academy of Veterinary Pharmacology and Therapeutics, Kalamazoo, MI, June 15-19, 1994 /
Published: (1994)

Guidance for FDA reviews and sponsors : content and review of chemistry, manufacturing, and control (CMC) information for human gene therapy investigational new drug applications (INDs).
Published: (2008)

Guidance for industry : alternate source of the active pharmaceutical ingredient in pending ANDAs.
Published: (2000)

Food and Drug Amendments of 2022 : report of the Committee on Energy and Commerce (to accompany H.R. 7667).
Published: (2022)

Guidance for industry : providing regulatory submissions in electronic format, general considerations.
Published: (1999)

Drugs : from discovery to approval /
by: Ng, Rick
Published: (2004)

Guidance for industry : classifying resubmissions in response to action letters.
Published: (1998)

Guidance for industry : PET drug applications : content and format for NDAs and ANDAs, fludeoxyglucose F 18 injection, ammonia N 13 injection, sodium fluoride F 18 injection.
Published: (2000)

Guidance for industry : environmental assessment of human drug and biologics applications.
Published: (1998)